Multiple Middle Eastern countries urgently lobby the U.S. to resume the US-Iran talks originally scheduled for the 6th

CryptocurrencySniper · 2026-02-04T21:22:47+00:00

On February 4th, Middle Eastern leaders urgently lobbied the Trump administration to resume the US-Iran nuclear negotiations. The meeting is scheduled to be held on the 6th in Oman. This move alleviated regional concerns about potential military conflict, with nine countries calling for continued dialogue. The Trump administration agreed to hold the meeting to respect allies and advance diplomatic efforts.

CryptocurrencySniper

2026-02-04 21:22:47

Abstract generation in progress

On February 4th, local time, CCTV reporters learned that after several Middle Eastern leaders urgently lobbied the Trump administration to abandon the threat of withdrawal negotiations on the afternoon of the same day, the planned US-Iran nuclear talks scheduled for the 6th were able to resume, and the negotiations will be held in Oman. The United States had earlier rejected Iran’s proposal to change the original meeting location from Istanbul, Turkey, to Oman.

It is reported that this deadlock has caused concern throughout the Middle East, with fears that Trump might resort to military action. At least nine countries in the region have contacted the White House through the highest-level channels, strongly urging the US not to cancel the meeting.

An American official said, “They asked us to continue the talks and listen to Iran’s side. We have told Arab countries that if they insist, we will hold the meeting. But we are very skeptical about this.” Another US official stated that the Trump administration agreed to hold the meeting to “respect” US allies in the region, “and to continue seeking diplomatic solutions.”

(Source: CCTV News Client)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.